Transition From Pediatric to Adult Care in Epilepsy
NCT07592676 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 64
Last updated 2026-05-18
Summary
The transition from pediatric to adult healthcare services for individuals with epilepsy represents a major clinical and organizational challenge. This complexity arises from the heterogeneity of the underlying epileptic disorders and the frequent presence of multiple comorbidities. Furthermore, the process entails a profound shift in the patient-physician relationship, which must be re-established to allow open discussion of sensitive issues and to adapt to a different model of care.
In pediatric settings, medical care is predominantly family-centered, with parents actively involved in the decision-making process. In contrast, adult care is primarily patient-centered, emphasizing individual autonomy and self-management. The \*\*transition\*\* therefore constitutes a structured process designed to prepare adolescents and young adults for adult-oriented healthcare. It aims to enhance their understanding of epilepsy, increase awareness of available treatments, and develop self-management skills that help minimize the long-term psychosocial and medical impact of the disorder.
The \*\*transfer\*\*, by contrast, refers to the formal handover of medical responsibility from pediatric to adult healthcare providers. While transfer is an event, transition represents a multidimensional process that should begin well before the actual shift of care.
Over the past decade, several studies have sought to address the challenges associated with this critical phase by proposing transitional programs based on different organizational models. These structured interventions are designed to bridge the gap between pediatric and adult services, fostering continuity of care and improving clinical outcomes.
A recent and promising example is a \*\*French transitional model\*\*, published following a retrospective study involving 70 persons with epilepsy (PWE). This model provided evidence supporting the feasibility and benefits of a dedicated, multidisciplinary transition program tailored to the specific needs of young individuals with epilepsy.
In contrast, within the Italian scientific and clinical context-particularly in the field of epilepsy-no formally structured or validated transition program has yet been established. This gap underscores the need for the development of standardized national guidelines and the implementation of evidence-based transitional pathways.
A well-designed transition program can significantly facilitate the adjustment of adolescents to adult neurological care, promoting therapeutic adherence, clinical stability, and psychosocial well-being. Ultimately, structured transitional care represents a crucial step toward ensuring continuity, safety, and quality of care for individuals with epilepsy as they move from pediatric to adult health services.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
EpiTRAQ
Clinical and neuropsychological evaluations with standardised and internationally validated questionnaires and interviews, already used in clinical practice.
Sponsors & Collaborators
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
lead OTHER
Principal Investigators
-
Domenica Immacolata Battaglia · Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-19
- Primary Completion
- 2028-12-01
- Completion
- 2030-12-01
Countries
- Italy
Study Locations
More Related Trials
-
Application of Novel Diagnostic and Therapeutical Methods in Epilepsy and Neurodevelopmental Abnormalities in Children.
NCT03486366 ·Status: UNKNOWN ·Phase: NA
-
Topiramate Treatment for Patients With Epilepsy and Learning Disability : A Prospective Observational Study
NCT00956696 ·Status: UNKNOWN
-
The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children
NCT05697614 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs
NCT01527006 ·Status: COMPLETED ·Phase: PHASE2
-
Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy
NCT00552526 ·Status: UNKNOWN ·Phase: PHASE4
-
A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures
NCT01393743 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures
NCT00297349 ·Status: COMPLETED
-
Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents
NCT01431976 ·Status: COMPLETED ·Phase: PHASE3
-
Idiopathic Generalized Epilepsy Cognitive and Emotional Profile
NCT06782074 ·Status: RECRUITING
-
Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
NCT02914314 ·Status: COMPLETED ·Phase: PHASE2
-
Symptoms of Post-traumatic Stress in Adult Drug-resistant Epilepsies
NCT04749901 ·Status: TERMINATED ·Phase: NA
-
Clinical Evaluation of the Efficacity of Epilepsy Surgery in Infants and Children
NCT02821260 ·Status: RECRUITING
-
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
NCT02849626 ·Status: COMPLETED ·Phase: PHASE3
-
Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG)
NCT05944692 ·Status: RECRUITING
-
Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy
NCT02736162 ·Status: COMPLETED
-
Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy
NCT00242606 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Epileptic Discharge on the Structural Connectivity of the Developing Brain
NCT03268824 ·Status: RECRUITING
-
An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects
NCT02427607 ·Status: COMPLETED ·Phase: PHASE3
-
Adherence to Pharmacological Antiepileptic Treatment in Adolescence
NCT05825807 ·Status: UNKNOWN
-
Sleep Related Memory Consolidation in Children With Age Related Focal Epilepsy.
NCT03865771 ·Status: RECRUITING ·Phase: NA
-
Cognitive Impact of Benzodiazepin Withdrawn After Curative Epilepsy Surgery in Children With Focal Epilepsy
NCT03803046 ·Status: TERMINATED
-
A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy
NCT04252846 ·Status: COMPLETED
-
Novel Network Analysis of Intracranial Stereoelectroencephalography
NCT03916848 ·Status: UNKNOWN ·Phase: NA
-
Epilepsy and Mood Regulation Disorder in Children
NCT02568813 ·Status: UNKNOWN ·Phase: NA
-
Prophylactic Anti-epileptic Regimen in Traumatic Brain Injury
NCT07535736 ·Status: NOT_YET_RECRUITING